Current Clinical Trials

1. Intravitreal sustained release Dexamethasone therapy for posterior and anterior uveitis

2. Novel "Natural" Protein for treatment of BSCR and Sarcoid uveitis

3. Must Trial (National Institutes of Health) - comparing oral corticosteriod verses Fluometholone Acetonide therapy for uveitis

4. P2Y2 recpetor agonist therapy for chronic uveitis (macular edema)

5. Novel therapy for Dry Eye

6. Longterm follow of anticancer medicine for macula edema, diabetic retinopathy, and macular degeneration

COMING SOON: Other monoclonal antibody therapy for recurrent or chronic ocular inflammatory disease.